Concentra's Post-IPO Trading Levels Based On 'Its Dominant Market Position,' Says Analyst
Concentra's Post-IPO Trading Levels Based On 'Its Dominant Market Position,' Says Analyst
"We see upside to Concentra's post-IPO trading levels based on the company's dominant market position as the country's leading occupational healthcare provider," RBC Capital noted.Concentra Group Holdings Inc (NYSE:CON) priced in July its initial public offering of 22.5 million shares at $23.50 per share.
Concentra Group Holdings Inc（紐交所：CON）在7月以每股23.50美元的價格定價其250萬股的首次公開發行。
RBC Capital Markets initiated coverage of Concentra, citing a "differentiated operating and reimbursement model with strong growth."
加拿大皇家銀行資本市場爲Concentra開展了覆蓋，並稱贊其具有「不同尋常的經營和報銷模型以及強勁的增長」。
RBC Capital analyst Ben Hendrix wrote Concentra offers a unique investment strategy with minimal exposure to regulatory and payor negotiation challenges faced by other providers, as its revenue mainly comes from employers and workers compensation rather than government or managed care reimbursements.
加拿大皇家銀行資本市場分析師本·亨德里克斯寫道，Concentra提供了一種獨特的投資策略，幾乎沒有面臨其它服務提供商面臨的監管和付款談判挑戰，因其收入主要來自僱主和工人賠償，而不是政府或管理護理報銷。
"We see upside to Concentra's post-IPO trading levels based on the company's dominant market position as the country's leading occupational healthcare provider," RBC Capital noted.
加拿大皇家銀行資本市場指出：「我們看到了Concentra在首次公開發行後的交易水平有望上升，這是基於該公司作爲全國領先的職業醫療保健服務提供商的卓越市場地位。」
The analyst initiated with an Outperform rating and a price target of $33.
該分析師以跑贏大盤爲評級調出啓動，並給出33美元的目標價。
Also Read: Concentra's High-Quality Business Model Attracts Analyst Attention, Initiates With Buy Rating.
另請參閱：Concentra的高質量商業模式吸引了分析師的注意，以買入評級啓動。
Since the IPO, Concentra's trading performance has closely mirrored that of its parent company, Select Medical Holdings Corp.'s subsidiary (NYSE:SEM).
自IPO以來，Concentra的交易表現與其母公司Select Medical Holdings Corp.（紐交所：SEM）的子公司密切呼應。
RBC Capital wrote that this valuation is too low for an independent entity with stronger profit margins and a more favorable reimbursement profile than Medicare-reimbursed post-acute care providers.
加拿大皇家銀行資本市場稱，對於利潤率更高且具有比醫保補償的後期護理服務提供商更有利的報銷結構的獨立實體來說，這一估值過低。
Although Concentra lacks direct public peers, RBC Capital analyst sees high-margin outpatient operators focused on musculoskeletal cases, such as Surgery Partners Inc (NASDAQ:SGRY) and U.S. Physical Therapy Inc (NYSE:USPH), as suitable comparisons.
雖然Concentra缺乏直接的公共同行，但加拿大皇家銀行資本市場分析師認爲，以肌肉骨骼病例爲重點的高利潤門診操作者，如Surgery Partners Inc（納斯達克：SGRY）和U.S. Physical Therapy Inc（紐交所：USPH），是合適的對比。
Given Concentra's more favorable reimbursement structure, the analyst expects its valuation to approach the 14.0x target as management executes its expansion plans and taps into a robust pipeline of growth opportunities.
鑑於Concentra更有利的報銷結構，分析師預計，在管理層執行其擴張計劃並利用龐大的增長機會管道的情況下，其估值將接近14.0倍目標。
Concentra provides occupational and consumer health services and other direct-to-employer care to more than 50,000 patients each day on average from 547 occupational health centers in 41 states and 154 onsite health clinics.
Concentra每天平均爲來自41個州的547個職業健康中心和154個現場衛生診所的超過50,000名患者提供職業和消費者健康服務以及其他直接面向僱主的護理服務。
The company has 11,000 employees.
該公司擁有11,000名員工。
CON Price Action: Concentra Group Holdings stock is down 0.73% at $23.18 at publication Tuesday.
CON股票價格行動：Concentra Group Holdings股票週二出版時下跌0.73％至23.18美元。
- Arbitration To Uncover Hidden Value Of Hess' Guyana Oil Assets In Exxon Mobil vs. Chevron Dispute: Report.
- 仲裁將揭示Hess在埃克森美孚對雪佛龍的糾紛中的圭亞那油資產的隱含價值：報告。
Photo: This Is Engineering via Upsplash
照片：This Is Engineering通過Upsplash
譯文內容由第三人軟體翻譯。
